Keensight Nova VII SCSp files amendment for Luxembourg-based private equity fund
Sold rose to $NaN (+$42.1M, +9 investors) in 365 days since the previous filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-10-30 | D | $0 | 0 | |
| 2026-10-30 | D/A | $42.1M | 9 | +$42.1M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Keensight Nova vehicles →
Sold rose to $NaN (+$42.1M, +9 investors) in 365 days since the previous filing.
| Xavier Rouviere | Executive Officer |
| N/A Keensight Nova VII GP S.a r.l. | Promoter |
| Ibrahim Jabri | Executive Officer |
| Arnaud Cohen | Executive Officer |
Signed by Xavier Rouviere, Class B Manager of the General Partner of the Issuer.
Placement agents / sales compensation: William Blair & Company, L.L.C.
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel.
The issuer's phone number and address from the filing are shown to subscribers. See plans.